ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1321

Effect of Subcutaneous Local Anaesthesia Prior to Intra-Articular Injection: An Open Label, Paired-group, Randomized Controlled Trial

Alan Shaji1, Varun Dhir2, Chandra Bhushan Prasad3, Shankar Naidu1, Aman Sharma4, Shefali Sharma5, Babita Ghai1 and Sanjay Jain1, 1PGIMER, Chandigarh, India, 2PGIMER, CHD, INDIA, Chandigarh, India, 3Healthway Hospital, Goa, Zuarinagar, India, 4PGIMER, Chandigarh, India, Chandigarh, India, 5PGIMER< Chandigarh, Chandigarh, India

Meeting: ACR Convergence 2023

Keywords: Intervention

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 13, 2023

Title: (1308–1344) RA – Treatments Poster II

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Intraarticular injections are commonly used both for diagnostic and therapeutic injections of glucocorticoids in patients with inflammatory arthritis. The procedural pain felt by patients may be an important factor for patients to consider future injections. Subcutaneous local anaesthesia given a few minutes prior may reduce the pain felt by the patient, however, has the disadvantage of pricking the patient twice. Once problem of studies comparing pain is that individual perception of pain varies, thus, we planned this study which included patients with two same (paired) joints swollen who were undergoing therapeutic joint injections.

Methods: This was an open-label (patients blinded) randomized controlled trial that included patients with rheumatoid arthritis or spondyloarthritis who had both (paired) medium-large joints swollen – either both knees or ankles or writs or elbows, and planned for therapeutic joint injections. The study design was that patients underwent intra-articular into left joint followed by right joint after a gap of 10-minutes. Whether the left or the right joint got local anesthesia was decided by using randomization (online software, serial permuted blocks). (Figure 1) Local anesthesia consisted of 5 ml lignocaine infiltrated in the skin and subcutaneous tissue using a 23-G needle. Intraarticular injections were given using a 10 ml syringe with a 21 G needle. Primary outcome was immediate procedural pain felt by the patient and secondary endpoints were 1-hour pain assessment, patient preference for future injections (after telling them which joint received LA) and complications. Pain was assessed using numerical rating scale. Paired t-test and Wilcoxon Signed Rank test was used to compare the intensity of pain. Trial registration number CTRI/2021/07/034777

Results: This study included 42 patients undergoing paired joint injections (84 joints). A majority of patients had rheumatoid arthritis (37, 88%), mean age (±SD) was 44.6 ± 14 years and 71% were females. The joints injected were knees (21 patients), wrists (14 patients), ankles (5 patients) and elbows (2 patients). There was a significantly lower immediate pain in the joint given local anaesthesia compared to that not given (difference -0.8, 95 CI -0.6 to -1.0) as well as significantly lower pain at 1-hour (difference -0.7, 95 CI -0.4 to -0.9). (Figure 2) A majority of patients (78.6%) preferred the procedure with local anaesthesia for future injections in their joints. There was no difference in complications of hypopigmentation or purpura nor in residual pain prick-site at 1-month. No significant differences were noted in pain by gender or age, nor by joint injected.

Conclusion: In this study with a unique paired design to obviate individual differences in pain, local anaesthesia of the overlying skin led to a definite but modest reduction (approximately 15%) in pain felt by the patient during intraarticular injection.

Supporting image 1

Figure 1: Study design

Supporting image 2

Figure 2: Immediate and 1-hour pain in the joint given prior local anesthesias versus the one not given local


Disclosures: A. Shaji: None; V. Dhir: None; C. Prasad: None; S. Naidu: None; A. Sharma: None; S. Sharma: None; B. Ghai: None; S. Jain: None.

To cite this abstract in AMA style:

Shaji A, Dhir V, Prasad C, Naidu S, Sharma A, Sharma S, Ghai B, Jain S. Effect of Subcutaneous Local Anaesthesia Prior to Intra-Articular Injection: An Open Label, Paired-group, Randomized Controlled Trial [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/effect-of-subcutaneous-local-anaesthesia-prior-to-intra-articular-injection-an-open-label-paired-group-randomized-controlled-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-subcutaneous-local-anaesthesia-prior-to-intra-articular-injection-an-open-label-paired-group-randomized-controlled-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology